All GLP-1 class drugs carry boxed warnings about thyroid C-cell tumors observed in rodent experiments, though this danger has not been verified in individuals. The SELECT cardiovascular results demo demonstrated that semaglutide actually decreased significant adverse cardiovascular occasions by 20%,